Shoreline Biosciences, Inc.
Shoreline's proprietary cell therapy technology platform is based on deep expertise in iPSC differentiation methods and genetic programming of the IL-15/CISH pathway for enhanced metabolic fitness and persistence of the engineered NK Cells to improve anti-cancer activity.
Shoreline Biosciences, Inc. Offices
OnSite Workspace
Employees work from physical offices.
Typical time on-site:
None
La Jolla, California, USA
